Only a few weeks into the new year Alligator updated the market on the progression of the phase Ib/II study OPTIMIZE-1, a new research collaboration, and about a new major shareholder joining Alligator's nomination committee. BioStock reached out to CEO Søren Bregenholt to get his view on the latest developments.
Read the interview with
https://www.biostock.se/2022/01/alligator-bioscience-on-the-latest-developments/
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/
https://news.cision.com/alligator-bioscience/r/biostock--alligator-bioscience-on-the-latest-developments,c3491288
(c) 2022 Cision. All rights reserved., source